Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 161 $ 165
Accounts receivable, net 19,455 16,871
Inventories 6,091 4,821
Other current assets 4,012 2,922
Total current assets 29,719 24,779
Medical equipment for sale or rental 3,975 2,790
Medical equipment in rental service, net of accumulated depreciation 35,278 39,450
Property & equipment, net of accumulated depreciation 4,233 4,385
Goodwill 3,710 3,710
Intangible assets, net 7,694 8,436
Operating lease right of use assets 4,291 4,168
Deferred income taxes 9,245 9,625
Derivative financial instruments 2,165 1,965
Other assets 1,761 80
Total assets 102,071 99,388
Current liabilities:    
Accounts payable 7,629 8,341
Current portion of long-term debt 0 0
Other current liabilities 6,646 6,126
Total current liabilities 14,275 14,467
Long-term debt, net of current portion 32,655 33,157
Operating lease liabilities, net of current portion 3,672 3,761
Total liabilities 50,602 51,385
Stockholders’ equity:    
Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued 0 0
Common stock, $0.0001 par value: authorized 200,000,000 shares; 21,183,526 shares issued and outstanding as of September 30, 2023 and 20,781,977 shares issued and outstanding as of December 31, 2022 2 2
Additional paid-in capital 108,530 105,856
Accumulated other comprehensive income 1,634 1,489
Retained deficit (58,697) (59,344)
Total stockholders’ equity 51,469 48,003
Total liabilities and stockholders’ equity $ 102,071 $ 99,388